Viking Therapeutics, Inc. (VKTX)
31.98
-0.15
(-0.47%)
USD |
NASDAQ |
Sep 11, 16:00
31.57
-0.41
(-1.28%)
After-Hours: 06:56
Viking Therapeutics Market Cap : 3.731B for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 3.731B |
| September 10, 2026 | 3.748B |
| September 09, 2026 | 3.815B |
| September 08, 2026 | 3.929B |
| September 04, 2026 | 4.068B |
| September 03, 2026 | 3.964B |
| September 02, 2026 | 3.908B |
| September 01, 2026 | 3.928B |
| August 31, 2026 | 3.824B |
| August 28, 2026 | 3.752B |
| August 27, 2026 | 3.950B |
| August 26, 2026 | 4.011B |
| August 25, 2026 | 3.986B |
| August 24, 2026 | 3.876B |
| August 21, 2026 | 3.953B |
| August 20, 2026 | 4.008B |
| August 19, 2026 | 4.197B |
| August 18, 2026 | 3.893B |
| August 17, 2026 | 3.923B |
| August 14, 2026 | 3.872B |
| August 13, 2026 | 3.843B |
| August 12, 2026 | 3.969B |
| August 11, 2026 | 3.943B |
| August 10, 2026 | 4.018B |
| August 07, 2026 | 3.997B |
| Date | Value |
|---|---|
| August 06, 2026 | 3.885B |
| August 05, 2026 | 3.909B |
| August 04, 2026 | 3.843B |
| August 03, 2026 | 3.804B |
| July 31, 2026 | 3.703B |
| July 30, 2026 | 3.862B |
| July 29, 2026 | 3.900B |
| July 28, 2026 | 3.950B |
| July 27, 2026 | 4.068B |
| July 24, 2026 | 4.032B |
| July 23, 2026 | 4.101B |
| July 22, 2026 | 4.324B |
| July 21, 2026 | 4.398B |
| July 20, 2026 | 4.216B |
| July 17, 2026 | 4.297B |
| July 16, 2026 | 4.215B |
| July 15, 2026 | 4.382B |
| July 14, 2026 | 4.400B |
| July 13, 2026 | 4.418B |
| July 10, 2026 | 4.504B |
| July 09, 2026 | 4.768B |
| July 08, 2026 | 4.631B |
| July 07, 2026 | 4.883B |
| July 06, 2026 | 4.486B |
| July 02, 2026 | 4.339B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 130.59B |
| Eli Lilly & Co. | 1.050T |
| Regeneron Pharmaceuticals, Inc. | 80.81B |
| Ironwood Pharmaceuticals, Inc. | 674.18M |
| Xencor, Inc. | 1.814B |
Market Cap Related Metrics
| PEG Ratio | -0.0337 |
| Price to Book Value | 9.136 |
| Price | 31.98 |
| Earnings Yield | -14.58% |
| PEGY Ratio | -0.0337 |